Department of Pharmacy, COMSATS Institute of Information Technology, 22060 Abbottabad, Pakistan.
Department of Chemistry, COMSATS Institute of Information Technology, 22060 Abbottabad, Pakistan.
Int J Biol Macromol. 2018 Jul 1;113:526-533. doi: 10.1016/j.ijbiomac.2018.02.135. Epub 2018 Feb 23.
The current study was designed to prepare surface modified BC matrices loaded with model drugs selected on the basis of their aqueous solubility, i.e., poorly water soluble famotidine and highly water soluble tizanidine. Fourier transform infrared (FT-IR) spectroscopy, X-ray diffraction (XRD), scanning electron microscopy (SEM) and thermogravimetric analysis (TGA) confirmed the successful drug loading and thermal stability of the BC matrices. In-vitro dissolution studies using USP type-II dissolution apparatus showed that most of the drug was released in 0.5-3h from famotidine loaded matrices and in 0.25-0.5h from tizanidine loaded matrices. The chemical structure, concentration of the loaded drug, concentration of the surface modifier, and pre- and post-drug loading modifications altered the physicochemical properties of BC matrices, which in turn affected the drug release behavior. In general, surface modification of the BC matrices enhanced the drug release retardant properties in pre-modification drug loading. Surface modification was found to be effective for controlling the drug release properties of BC. Therefore, these modified BC matrices have the potential for applications in modified drug delivery systems.
本研究旨在制备表面改性的 BC 基质,载药模型的选择基于其水溶性,即水溶性差的法莫替丁和水溶性好的替扎尼定。傅里叶变换红外(FT-IR)光谱、X 射线衍射(XRD)、扫描电子显微镜(SEM)和热重分析(TGA)证实了 BC 基质的成功载药和热稳定性。使用 USP Ⅱ型溶出仪进行的体外溶出研究表明,大部分药物从载有法莫替丁的基质中在 0.5-3h 内释放,从载有替扎尼定的基质中在 0.25-0.5h 内释放。载药前和载药后的化学结构、载药浓度、表面改性剂浓度改变了 BC 基质的物理化学性质,从而影响了药物释放行为。一般来说,BC 基质的表面改性增强了预改性载药时的药物释放延缓性能。表面改性可有效控制 BC 的药物释放性质。因此,这些改性的 BC 基质有望应用于改良的药物传递系统。